Kallyope IPO

kallyope.com

Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis by integrating cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology that will lead to transformational therapeutics that improve human health.

Founded2015
Total Funding to Date$479.46MM
Register for Details

For more details on financing and valuation for Kallyope, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Kallyope Ticker Symbol

Kallyope does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Kallyope Stock Price

The stock price for Kallyope will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Kallyope Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
2/15/2022 Series D $1.27B $XXX.XX $XXX.XX
3/25/2020 Series C $496.5MM $XXX.XX $XXX.XX
12/5/2018 Series B $231.7MM $XXX.XX $XXX.XX
12/11/2015 Series A $67.77MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Kallyope in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM